Is DocuSign Stock Undervalued?
Digital signature software business DocuSign (NASDAQ:DOCU) has been struggling over…
Sell
49
MIRA Quote, Financials, Valuation and Earnings
Last price:
$1.52
Seasonality move
:
7.97%
Day range:
$1.55 - $1.59
52-week range:
$0.73 - $2.45
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
--
P/B ratio:
8.76x
Volume:
48.3K
Avg. volume:
265.8K
1-year change:
43.64%
Market cap:
$66.2M
Revenue:
--
EPS (TTM):
-$1.52
Earnings Data
Next earnings date for MIRA
--
Most recent earnings per share
-$1.18
Missed by $1.10
(Nov 12/2025)
Consensus Estimate
-$0.08
(Nov 12/2025)
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
MIRA Quarterly Earnings History
| Date | Quarter | Revenue Forecast | Actual Revenue | Reported EPS | Consensus EPS | Beat/Miss |
|---|---|---|---|---|---|---|
| 12/31/2025 | Q4 | -- | -- | -- | -- | -- |
| 11/12/2025 | Q3 | -- | -- | -$1.18 | -$0.08 | -$1.10 |
| 08/14/2025 | Q2 | -- | -- | -$0.09 | -$0.13 | $0.04 |
| 05/14/2025 | Q1 | -- | -- | -$0.11 | -$0.15 | $0.04 |
| 12/31/2024 | Q4 | -- | -- | -$0.15 | -$0.24 | $0.09 |
| 11/12/2024 | Q3 | -- | -- | -$0.14 | -$0.15 | $0.01 |
| 08/13/2024 | Q2 | -- | -- | -$0.11 | -$0.11 | -- |
| 05/13/2024 | Q1 | -- | -- | -$0.12 | -$0.10 | -$0.02 |
| 02/29/2024 | Q4 | -- | -- | -$0.39 | -- | -- |
| 11/13/2023 | Q3 | -- | -- | -$0.26 | -$0.08 | -$0.18 |
| 09/15/2023 | Q2 | -- | -- | -$0.09 | -- | -- |
| 03/31/2023 | Q1 | -- | -- | -$0.10 | -- | -- |
| 12/31/2022 | Q4 | -- | -- | -$0.08 | -- | -- |
| 09/30/2022 | Q3 | -- | -- | -$0.10 | -- | -- |
| 06/30/2022 | Q2 | -- | -- | -$0.14 | -- | -- |
| 03/31/2022 | Q1 | -- | -- | -$0.10 | -- | -- |
MIRA Pharmaceuticals, Inc. Earnings Questions
-
How Much did MIRA Pharmaceuticals, Inc. Generate in Revenue Last Quarter?
MIRA Pharmaceuticals, Inc. reported -- worth of top line sales in its most recent quarter.
-
Did MIRA Pharmaceuticals, Inc. Beat Earnings Last Quarter?
MIRA Pharmaceuticals, Inc. announced earnings per share of -$1.18 which represents a miss of analyst forecast a -$0.08 per share.
-
Is MIRA Pharmaceuticals, Inc. Profitable?
MIRA Pharmaceuticals, Inc. reported -- that represents -- per share over the last quarter.
-
What is the Analyst Consensus for MIRA Pharmaceuticals, Inc. EPS Next Year?
MIRA Pharmaceuticals, Inc.'s earnings are forecast to decrease from -$0.51 per share to -$0.59 per share next year representing a decrease of -130.09%.
-
When is MIRA Pharmaceuticals, Inc.'s Earnings Date?
Currently, MIRA Pharmaceuticals, Inc. has not yet stated when its earnings date is, however, based on past estimates it's likely to take place on March 27, 2026.
SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS
GET BETTER TRADE IDEAS
Popular
Is SentinelOne Stock Undervalued?
Cybersecurity major SentinelOne (NYSE:S) has struggled over several years, delivering…
Is Broadcom Stock on Sale?
Chip and software maker Broadcom (NASDAQ:AVGO) has been among the…
Stock Ideas
Buy
57
Is NVDA Stock a Buy?
Market Cap: $4.6T
P/E Ratio: 64x
Buy
55
Is AAPL Stock a Buy?
Market Cap: $4T
P/E Ratio: 37x
Buy
61
Is GOOG Stock a Buy?
Market Cap: $3.8T
P/E Ratio: 39x
Alerts
Buy
80
TVTX alert for Dec 26
Travere Therapeutics, Inc. [TVTX] is down 0.7% over the past day.
Buy
64
ZCSH alert for Dec 26
Grayscale Zcash Trust (ZEC) [ZCSH] is down 2.08% over the past day.
Buy
66
ASTS alert for Dec 26
AST Spacemobile, Inc. [ASTS] is down 8.14% over the past day.
